Overexpression of A3 adenosine receptors in smooth, cardiac, and skeletal muscle is lethal to embryos

被引:25
作者
Zhao, ZH
Yaar, R
Ladd, D
Cataldo, LA
Ravid, K
机构
[1] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
关键词
D O I
10.1006/mvre.2001.2366
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The profile of expression of the A3 adenosine receptor (A3AR) and its importance during embryo development were explored. To this end, different ages of mouse embryos (8.5 days and older) were subjected to in situ hybridization with an A3AR riboprobe. No expression was found in any embryonic tissue except for the aorta and heart of 15.5-day embryos. To investigate further the role of the A3AR gene in development, we overexpressed this gene in A3AR knockout and wild-type mice by using the SM22alpha promoter. This promoter is active in smooth, cardiac, and skeletal muscle lineages during early embryogenesis (at 8.5 days or earlier), becoming restricted to vascular and visceral smooth muscle cells in late fetal development and adult mice. We observed that moderate copy number incorporation (four copies) of the A3AR gene driven by the SM22alpha promoter is sufficient to induce lethality at an early stage of embryo development. Remains of 8.5-day transgenic embryos were collected, including fragmented DNA. Hence, we speculate that A3AR homeostasis is critical for embryo viability and proper development. This finding is intriguing in view of the reported effects of sustained activation of the A3AR on induction of DNA fragmentation and apoptosis in cultured myocytes and other cell types. (C) 2001 Elsevier Science.
引用
收藏
页码:61 / 69
页数:9
相关论文
共 32 条
[1]  
Abbracchio MP, 1995, MOL PHARMACOL, V48, P1038
[2]   Cardiovascular overexpression of transforming growth factor-β1 causes abnormal yolk sac vasculogenesis and early embryonic death [J].
Agah, R ;
Prasad, KS ;
Linnemann, R ;
Firpo, MT ;
Quertermous, T ;
Dichek, DA .
CIRCULATION RESEARCH, 2000, 86 (10) :1024-1030
[3]   Adenosine receptor subtypes in the heart: therapeutic opportunities and challenges [J].
Auchampach, JA ;
Bolli, R .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (03) :H1113-H1116
[4]   CARDIOVASCULAR AND RESPIRATORY EFFECTS OF ADENOSINE IN CONSCIOUS MAN - EVIDENCE FOR CHEMORECEPTOR ACTIVATION [J].
BIAGGIONI, I ;
OLAFSSON, B ;
ROBERTSON, RM ;
HOLLISTER, AS ;
ROBERTSON, D .
CIRCULATION RESEARCH, 1987, 61 (06) :779-786
[5]   Activation of the A3 adenosine receptor affects cell cycle progression and cell growth [J].
Brambilla, R ;
Cattabeni, F ;
Ceruti, S ;
Barbieri, D ;
Franceschi, C ;
Kim, YC ;
Jacobson, KA ;
Klotz, KN ;
Lohse, MJ ;
Abbracchio, MP .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 361 (03) :225-234
[6]   G-protein-coupled receptors: turn-ons and turn-offs [J].
Carman, CV ;
Benovic, JL .
CURRENT OPINION IN NEUROBIOLOGY, 1998, 8 (03) :335-344
[7]  
Coppee F, 1996, ONCOGENE, V13, P1471
[8]   Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor [J].
Dougherty, C ;
Barucha, J ;
Schofield, PR ;
Jacobson, KA ;
Liang, BT .
FASEB JOURNAL, 1998, 12 (15) :1785-1792
[9]   Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor [J].
Fishman, P ;
Bar-Yehuda, S ;
Ohana, G ;
Pathak, S ;
Wasserman, L ;
Barer, F ;
Multani, AS .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1452-1458
[10]   Transgenic A1 adenosine receptor overexpression markedly improves myocardial energy state during ischemia-reperfusion [J].
Headrick, JP ;
Gauthier, NS ;
Berr, SS ;
Morrison, RR ;
Matherne, GP .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (05) :1059-1064